`Doc code: IDS
`Approved for use through 07/31/2012. OMB 0651-0031
`Doc description: Information Disclosure Statement (IDS) Filed
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Number
`Filing Date
`First Named Inventor Robert Frederick Veasey
`Art Unit
`Examiner Name
`Attorney Docket Number
`
`TBD
`
`TBD
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`10-1188-US-CON4
`
`Examiner Cite
`Initial*
`No
`
`Patent Number
`
`Kind
`Code1
`
`Issue Date
`
`Name of Patentee or Applicant
`of cited Document
`
`Pages,Columns,Lines where
`Relevant Passages or Relevant
`Figures Appear
`
`U.S. PATENTS
`
`Remove
`
`1
`
`5626566
`
`A
`
`1997-05-06
`
`Petersen et al.
`
`2
`
`6083197
`
`A
`
`2000-07-04
`
`Umbaugh
`
`3
`
`6221046
`
`B1
`
`2001-04-24
`
`Burroughs et al.
`
`4
`
`6899698
`
`B2
`
`2005-05-31
`
`Sams
`
`5
`
`5688251
`
`A
`
`1997-11-18
`
`Chanoch
`
`6
`
`5674204
`
`A
`
`1997-10-07
`
`Chanoch
`
`7
`
`5304152
`
`A
`
`1994-04-19
`
`Sams
`
`If you wish to add additional U.S. Patent citation information please click the Add button.
`U.S.PATENT APPLICATION PUBLICATIONS
`
`Add
`Remove
`
`EFS Web 2.1.17
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 1 of 165
`
`
`
`Application Number
`Filing Date
`First Named Inventor Robert Frederick Veasey
`Art Unit
`Examiner Name
`Attorney Docket Number
`
`TBD
`
`TBD
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`10-1188-US-CON4
`
`Examiner
`Initiar
`
`Cite No
`
`Publication
`Number
`
`Kind Publication
`Code1 Date
`
`Name of Patentee or Applicant
`of cited Document
`
`Pages,Columns,Lines where
`Relevant Passages or Relevant
`Figures Appear
`
`1
`
`2
`
`20020052578
`
`A1
`
`2002-05-02
`
`Moller
`
`20040059299
`
`A1
`
`2004-03-25
`
`Moller et al.
`
`If you wish to add additional U.S. Published Application citation information please click the Add button. Add
`Remove
`FOREIGN PATENT DOCUMENTS
`
`Examiner Cite
`Initiar
`No
`
`Foreign Document
`Number3
`
`Country
`Code2
`j
`
`Kind Publication
`Code4 Date
`
`Name of Patentee or
`Applicant of cited
`Document
`
`Pages,Columns.Lines
`where Relevant
`Passages or Relevant
`Figures Appear
`
`T5
`
`1
`
`0937476
`
`2
`
`0937471
`
`EP
`
`EP
`
`A2
`
`1999-08-25
`
`Becton, Dickinson and
`Company
`
`A2
`
`1999-08-25
`
`Becton, Dickinson and
`Company
`
`3
`
`91/14467
`
`WO
`
`A1
`
`1991-10-03
`
`SAMS BERNARD
`
`4
`
`99/38554
`
`WO
`
`A1
`
`1999-08-05
`
`NOVO NORDISK AS
`
`•
`
`•
`
`•
`
`•
`
`If you wish to add additional Foreign Patent Document citation information please click the Add button
`NON-PATENT LITERATURE DOCUMENTS
`
`Add
`Remove
`
`Examiner Cite
`Initials* No
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item
`(book, magazine, journal, serial, symposium, catalog, etc), date, pages(s), volume-issue number(s),
`publisher, city and/or country where published.
`
`T5
`
`EFS Web 2.1.17
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 2 of 165
`
`
`
`Application Number
`Filing Date
`First Named Inventor Robert Frederick Veasey
`Art Unit
`Examiner Name
`Attorney Docket Number
`
`TBD
`
`TBD
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`10-1188-US-CON4
`
`1
`
`n
`
`If you wish to add additional non-patent literature document citation information please click the Add button Add
`EXAMINER SIGNATURE
`
`Examiner Signature
`
`Date Considered
`
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through a
`citation if not in conformance and not considered. Include copy of this form with next communication to applicant.
`
`1 See Kind Codes of USPTO Patent Documents at www.USPTO.GOV or MPEP 901.04. 2 Enter office that issued the document, by the two-letter code (WIPO
`Standard ST.3). 3 For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial number of the patent document.
`4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST. 16 if possible. 5 Applicant is to place a check mark here if
`English language translation is attached.
`
`EFS Web 2.1.17
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 3 of 165
`
`
`
`Application Number
`Filing Date
`First Named Inventor Robert Frederick Veasey
`Art Unit
`Examiner Name
`Attorney Docket Number
`
`TBD
`
`TBD
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`10-1188-US-CON4
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection(s):
`
`CERTIFICATION STATEMENT
`
`n
`
`That each item of information contained in the information disclosure statement was first cited in any communication
`from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the
`information disclosure statement. See 37 CFR 1.97(e)(1).
`
`OR
`
`That no item of information contained in the information disclosure statement was cited in a communication from a
`foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification
`after making reasonable inquiry, no item of information contained in the information disclosure statement was known to
`any individual designated in 37 CFR 1.56(c) more than three months prior to the filing of the information disclosure
`statement. See 37 CFR 1.97(e)(2).
`
`•
`
`Q See attached certification statement.
`• The fee set forth in 37 CFR 1.17 (p) has been submitted herewith,
`[x] A certification statement is not submitted herewith.
`
`SIGNATURE
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the
`form of the signature.
`
`Signature
`Name/Print
`
`/Thomas E. Wettermann/
`
`Thomas E. Wettermann
`
`Date (YYYY-MM-DD)
`Registration Number
`
`2013-06-04
`41523
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the
`public which is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR
`1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the completed
`application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you
`require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S.
`Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND
`FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria,
`VA 22313-1450.
`
`EFS Web 2.1.17
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 4 of 165
`
`
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the
`attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised
`that: (1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited
`is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office is to
`process and/or examine your submission related to a patent application or patent. If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act
`(5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the
`Department of Justice to determine whether the Freedom of Information Act requires disclosure of these record s.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from the
`Member with respect to the subject matter of the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for
`the information in order to perform a contract. Recipients of information shall be required to comply with the
`requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`
`5.
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant
`to the Patent Cooperation Treaty.
`
`6.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or
`his/her designee, during an inspection of records conducted by GSA as part of that agency's responsibility to
`recommend improvements in records management practices and programs, under authority of 44 U.S.C. 2904 and
`2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not be used to make
`determinations about individuals.
`
`8.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record
`may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record was filed in
`an application which became abandoned or in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`0
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`
`EFS Web 2.1.17
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 5 of 165
`
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`(Attorney Docket No.: 10-1188-US-CON4)
`
`Applicant:
`
`Appl. No.:
`
`Filed:
`
`Title:
`
`Veasey et al.
`
`Unassigned, Continuation of 12/944,544
`
`June 4,2013
`
`Pen-Type Injector
`
`FILED VIA EFS-WEB
`ON JUNE 4, 2013
`
`TC/A.U.:
`
`TBD
`
`Confirmation No.:
`
`TBD
`
`Examiner:
`
`TBD
`
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`
`GENERAL AUTHORIZATIONS UNDER 37 C.F.R. SS 1.25fl^ and 1.136(aW3)
`
`In this or any related application filed pursuant to 37 C.F.R. § 1.53, for the entire pendency
`
`thereof, and with respect to Deposit Account No. 132490, the Commissioner is hereby generally
`
`authorized:
`
`(a)
`
`under 37 C.F.R. § 1.25(b), subject to the provisions of 37 C.F.R. § 1.311(b), to charge all
`
`fees set forth in 37 C.F.R. §§ 1.16 to 1.18; and
`
`(b)
`
`under 37 C.F.R. § 1.136(a)(3) to treat any future reply requiring an extension of time as
`
`incorporating a request therefor, and specifically to charge any fee that may be due in connection with
`
`such a request.
`
`Date: June 4, 2013
`
`MCDONNELLBOEHNEN
`HULBERT & BERGHOFF LLP
`300 SOUTH WACKER DRIVE
`CHICAGO, ILLINOIS 60606
`TELEPHONE (312) 913-0001
`
`Respectfully submitted,
`MCDONNELL BOEHNEN
`HULBERT & BERGHOFF LLP
`
`By:
`
`/Thomas E. Wettermann/
`Thomas E. Wettermann
`Reg. No. 41,523
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 6 of 165
`
`
`
`Electronic Patent Application Fee Transmittal
`
`Application Number:
`
`Filing Date:
`
`Title of Invention:
`
`Pen-Type Injector
`
`First Named Inventor/Applicant Name:
`
`Robert Frederick Veasey
`
`Filer:
`
`Thomas E. Wettermann
`
`Attorney Docket Number:
`
`10-1188-US-CON4
`
`Filed as Large Entity
`
`Utility under 35 USC 111 (a) Filing Fees
`
`Description
`
`Fee Code
`
`Quantity
`
`Amount
`
`Sub-Total in
`USD($)
`
`Utility application filing
`
`Utility Search Fee
`
`Utility Examination Fee
`
`1011
`
`1 1 1 1
`
`1311
`
`1
`
`1
`
`1
`
`280
`
`600
`
`720
`
`280
`
`600
`
`720
`
`Basic Filing:
`
`Pages:
`
`Claims:
`
`Claims in Excess of 20
`
`1202
`
`36
`
`80
`
`2880
`
`Miscellaneous-Filing:
`
`Petition:
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 7 of 165
`
`
`
`Description
`
`Fee Code
`
`Quantity
`
`Amount
`
`Sub-Total in
`USD($)
`
`Patent-Appeals-and-lnterference:
`
`Post-Allowance-and-Post-lssuance:
`
`Extension-of-Time:
`
`Miscellaneous:
`
`Total in USD ($)
`
`4480
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 8 of 165
`
`
`
`Electronic Acknowledgement Receipt
`
`EFSID:
`
`Application Number:
`
`15945172
`
`13909681
`
`International Application Number:
`
`Confirmation Number:
`
`8309
`
`Title of Invention:
`
`Pen-Type Injector
`
`First Named Inventor/Applicant Name:
`
`Robert Frederick Veasey
`
`Customer Number:
`
`20306
`
`Filer:
`
`Thomas E. Wettermann
`
`Filer Authorized By:
`
`Attorney Docket Number:
`
`10-1188-US-CON4
`
`Receipt Date:
`
`Filing Date:
`
`Time Stamp:
`
`04-JUN-2013
`
`16:38:07
`
`Application Type:
`
`Utility under 35 USC 111(a)
`
`Payment information:
`
`Submitted with Payment
`
`Payment Type
`
`Payment was successfully received in RAM
`RAM confirmation Number
`
`Deposit Account
`
`Authorized User
`
`yes
`
`Deposit Account
`
`$4480
`
`3923
`
`132490
`
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`Charge any Additional Fees required under 37 C.F.R. Section 1.19 (Document supply fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.20 (Post Issuance fees)
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 9 of 165
`
`
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.21 (Miscellaneous fees and charges)
`
`File Listing:
`Document
`Number
`
`Document Description
`
`File Name
`
`File Size( Bytes)/
`Message Digest
`
`Multi
`Part /.zip
`
`Pages
`(ifappl.)
`
`1
`
`Transmittal of New Application
`
`10_1188_US_CON4_Utility_Tra
`nsmittal_2013_06_04.pdf
`
`276088
`
`3e8653d3222d6147f389485d4c271bc54de
`862c0
`
`no
`
`2
`
`Warnings:
`Information:
`
`2
`
`Application Data Sheet
`
`10_1188_US_CON4_ADS_2013
`_06_04.pdf
`
`1504242
`
`44cabd28dbb88c73b230d440164d8a6f2f4
`b0bf3
`
`no
`
`7
`
`Warnings:
`Information:
`
`3
`
`Warnings:
`Information:
`
`10_1188_US_CON4_Specificati
`on_2013_06_04.pdf
`
`85841
`
`yes
`
`15
`
`fa486066f8421 a7dba79a83acb1154786dcc
`2f2b
`
`Multipart Description/PDF files in .zip description
`
`Document Description
`
`Start
`
`End
`
`Specification
`
`Claims
`
`Abstract
`
`1
`
`1 2
`
`15
`
`1 1
`
`14
`
`15
`
`4
`
`Drawings-only black and white line
`drawings
`
`10_1188_US_CON4_Figures_2
`013_06_04.pdf
`
`518548
`
`76ed17b52ef22fbdc08076af060ed1 a90433
`40f2
`
`no
`
`7
`
`Warnings:
`Information:
`
`5
`
`Preliminary Amendment
`
`10_1188_US_CON4_Preliminar
`y_Amendment_2013_06_04.
`
`104251
`
`ace75dc1850856272d467e5d7bba4fe6eff4
`1893
`
`no
`
`14
`
`Warnings:
`Information:
`
`6
`
`Oath or Declaration filed
`
`10_1188_US_CON4_Declaratio
`n_2013_06_04.pdf
`
`525668
`
`6ec2d689376d92e6f6213aee0b5b219d5b6
`f7b1a
`
`no
`
`4
`
`Warnings:
`Information:
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 10 of 165
`
`
`
`7
`
`Transmittal Letter
`
`10_1188_US_CON4_IDS_Trans
`mittal_2013_06_04.pdf
`
`80655
`
`de5c28e47721e8305459107ebf4eda94e2f
`1a7f7
`
`no
`
`2
`
`Warnings:
`Information:
`
`8
`
`Information Disclosure Statement (IDS) 10_1188_US_CON4_IDS_2013_
`Form (SB08)
`06_04.pdf
`
`612830
`
`88d20c1077c15f5820e6977fbc9360b3b54
`b8f0e
`
`no
`
`5
`
`Warnings:
`Information:
`
`9
`
`Authorization for Extension of Time all
`replies
`
`10_1188_US_CON4_General_A
`uthorization_2013_06_04.pdf
`
`81376
`
`no
`
`1
`
`6cecf2438081ae759d05c50c44db8f57f497
`61d4
`
`Warnings:
`Information:
`
`10
`
`Fee Worksheet (SB06)
`
`fee-info.pdf
`
`no
`
`2
`
`36267
`
`34540e7d56982c9aefe7af59e4140aee5671
`4cf8
`
`Warnings:
`Information:
`
`Total Files Size (in bytes):
`
`3825766
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 11 of 165
`
`
`
`r
`
`PTO/AIA/15 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number
`
`UTILITY
`PATENT APPLICATION
`TRANSMITTAL
`
`Attorney Docket No.
`
`First Named Inventor
`
`Title
`
`10-1188-US-CON4
`Robert Frederick Veasey
`Pen-Type Injector
`
`>
`
`(Only for new nonprovisional applications under 37 CFR 1.53(b))
`
`Express Mail Label No.
`
`J
`
`APPLICATION ELEMENTS
`See MPEP chapter 600 concerning utility patent application contents.
`
`1.
`
`2.
`
`3.
`
`8.
`
`Fee Transmittal Form
`(PTO/SB/17 or equivalent)
`Applicant asserts small entity status.
`See 37 CFR 1.27
`Applicant certifies micro entity status. See 37 CFR 1.29.
`Applicant must attach form PTO/SB/15A or B or equivalent.
`15
`4. [^] Specification
`[Total Pages
`Both the claims and abstract must start on a new page.
`(See MPEP § 608.01(a) for information on the preferred arrangement)
`5.1 ^ I Drawing(s) (35 U.S.C. 113)
`[Total Sheets
`]
`6. Inventor's Oath or Declaration
`[Total Pages
`]
`(including substitute statements under 37 CFR 1.64 and assignments
`serving as an oath or declaration under 37 CFR 1.63(e))
`a. |^] Newly executed (original or copy)
`b.
`A copy from a prior application (37 CFR 1.63(d))
`7. | ^ | Application Data Sheet
`* See note below.
`See 37 CFR 1.76 (PTO/AIA/14 or equivalent)
`CD-ROM or CD-R
`in duplicate, large table, or Computer Program (Appendix)
`| Landscape Table on CD
`|
`9. Nucleotide and/or Amino Acid Sequence Submission
`(if applicable, items a. - c. are required)
`a. |
`| Computer Readable Form (CRF)
`b.|
`| Specification Sequence Listing on:
`i. |^| CD-ROM or CD-R (2 copies); or
`ii. |
`| Paper
`Statements verifying identity of above copies
`
`c.
`
`ADDRESS TO:
`
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`ACCOMPANYING APPLICATION PAPERS
`Assignment Papers
`(cover sheet & document(s))
`Name of Assignee
`
`10.
`
`|
`
`| Power of Attorney
`
`12.
`
`16.
`
`17.
`
`11. Q 37 CFR 3.73(c) Statement
`[when there is an assignee)
`English Translation Document
`[if applicable)
`13. [^] Information Disclosure Statement
`(PTO/SB/OS or PTO-1449)
`|
`| Copies of citations attached
`14. [^] Preliminary Amendment
`Return Receipt Postcard
`15.
`(MPEP § 503) (Should be specifically itemized)
`Certified Copy of Priority Document(s)
`[if foreign priority is claimed)
`Nonpublication Request
`Under 35 U.S.C. 122(b)(2)(B)(i). Applicant must attach form PTO/SB/35
`or equivalent.
`18. Q Other: General Authorization
`
`*Note: (1) Benefit claims under 37 CFR 1.78 and foreign priority claims under 1.55 must be included in an Application Data Sheet (ADS).
`(2) For applications filed under 35 U.S.C. Ill, the application must contain an ADS specifying the applicant if the applicant is an
`assignee, person to whom the inventor is under an obligation to assign, or person who otherwise shows sufficient proprietary
`interest in the matter. See 37 CFR 1.46(b).
`19. CORRESPONDENCE ADDRESS
`
`| ^ | The address associated with Customer Number:
`
`20306
`
`OR
`
`Correspondence address below
`
`Name
`
`Address
`
`City
`
`State
`
`Country
`Telephone
`T
`/Thomas E. Wettermann/
`Signature
`Name
`L (Print/Type) Thomas E. Wettermann
`
`Registration No.
`(Attorney/Agent)
`This collection of information is required by 37 CFR 1.53(b). The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO
`to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 12 minutes to complete,
`including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on
`the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND
`TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`//you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
`
`Zip Code
`
`
`Date
`
`June 4, 2013
`41,523
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 12 of 165
`
`
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your
`submission of the attached form related to a patent application or patent. Accordingly, pursuant to the
`requirements of the Act, please be advised that: (1) the general authority for the collection of this information is
`35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which
`the information is used by the U.S. Patent and Trademark Office is to process and/or examine your submission
`related to a patent application or patent. If you do not furnish the requested information, the U.S. Patent and
`Trademark Office may not be able to process and/or examine your submission, which may result in termination
`of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of
`Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of
`records may be disclosed to the Department of Justice to determine whether disclosure of these
`records is required by the Freedom of Information Act.
`A record from this system of records may be disclosed, as a routine use, in the course of presenting
`evidence to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel in
`the course of settlement negotiations.
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress
`submitting a request involving an individual, to whom the record pertains, when the individual has
`requested assistance from the Member with respect to the subject matter of the record.
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency
`having need for the information in order to perform a contract. Recipients of information shall be
`required to comply with the requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C.
`552a(m).
`A record related to an International Application filed under the Patent Cooperation Treaty in this
`system of records may be disclosed, as a routine use, to the International Bureau of the World
`Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`A record in this system of records may be disclosed, as a routine use, to another federal agency for
`purposes of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act
`(42 U.S.C. 218(c)).
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General
`Services, or his/her designee, during an inspection of records conducted by GSA as part of that
`agency's responsibility to recommend improvements in records management practices and programs,
`under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the
`GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or
`Commerce) directive. Such disclosure shall not be used to make determinations about individuals.
`A record from this system of records may be disclosed, as a routine use, to the public after either
`publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35
`U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine
`use, to the public if the record was filed in an application which became abandoned or in which the
`proceedings were terminated and which application is referenced by either a published application, an
`application open to public inspection or an issued patent.
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local
`law enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or
`regulation.
`
`3.
`
`4
`
`5.
`
`Q
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 13 of 165
`
`
`
`PTO/AIA/14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`Application Number
`
`10-1188-US-CON4
`
`Title of Invention
`
`Pen-Type Injector
`
`The application data sheet is part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included in a paper filed application.
`
`Secrecy Order 37 CFR 5.2
`Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`EH 37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`Inventor Information:
`
`Inventor 1
`Legal Name
`
`Remove
`
`Family Name
`Prefix Given Name
`Middle Name
`Veasey
`Robert
`Frederick
`Residence Information (Select One) Q US Residency
`(•) Non US Residency 0 Active US Military Service
`City
`Country of Residence i
`Warwickshire
`
`GB
`
`Suffix
`
`Mailing Address of Inventor:
`
`31 Lonsdale Road
`Leamington Spa
`
`Warwickshire
`
`CV327EP
`
`State/Province
`Country i
`GB
`
`Address 1
`Address 2
`City
`Postal Code
`
`2
`Inventor
`Legal Name
`
`Remove
`
`Family Name
`Prefix Given Name
`Perkins
`Robert
`Residence Information (Select One) Q US Residency
`(•) Non US Residency 0 Active US Military Service
`City
`Country of Residence i
`Oxfordshire
`
`Middle Name
`
`GB
`
`Suffix
`
`Mailing Address of Inventor:
`
`Address 1
`Address 2
`City
`Postal Code
`
`6 Printers Court Abingdon
`
`Oxfordshire
`
`OX14 SBZ
`
`State/Province
`Country i
`GB
`
`Inventor 3
`Legal Name
`
`EFS Web 2.2.6
`
`Remove
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 14 of 165
`
`
`
`PTO/AIA/14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`10-1188-US-CON4
`Attorney Docket Number
`Application Number
`
`Application Data Sheet 37 CFR 1.76
`
`Title of Invention
`
`Pen-Type Injector
`
`Family Name
`Middle Name
`Prefix Given Name
`David
`Aubrey
`Plumptre
`Residence Information (Select One) Q US Residency
`(•) Non US Residency 0 Active US Military Service
`City
`Country of Residence i
`Worcestershire
`
`GB
`
`Suffix
`
`Mailing Address of Inventor:
`
`Address 1
`36 Shire Way
`Address 2
`Droitwich
`State/Province
`City
`Worcestershire
`Country i
`Postal Code
`WR97
`GB
`All Inventors Must Be Listed - Additional Inventor Information blocks may be
`generated within this form by selecting the Add button.
`
`Add
`
`Correspondence Information:
`Enter either Customer Number or complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`Q An Address is being provided for the correspondence Information of this application.
`Customer Number
`Email Address
`
`20306
`
`docketing@mbhb.com
`
`Add Email
`
`Remove Email
`
`Small Entity Status Claimed Q
`
`Application Information:
`Title of the Invention
`Pen-Type Injector
`Attorney Docket Number 10-1188-US-CON4
`Application Type
`Nonprovisional
`Subject Matter
`Utility
`Total Number of Drawing Sheets (if any)
`Publication Information:
`• Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`R6C|U6St Not to Publish. I hereby request that the attached application not be published under
`Q 35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen months after filing.
`
`7
`
`Suggested Figure for Publication (if any)
`
`Representative Information:
`
`EFS Web 2.2.6
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1008, p. 15 of 165
`
`
`
`PTO/AIA/14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`10-1188-US-CON4
`Attorney Docket Number
`Application Number
`
`Application Data Sheet 37 CFR 1.76
`
`Title of Invention
`
`Pen-Type Injector
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below. If both sections are completed the customer
`Number will be used for the Representative Information during processing.
`
`Please Select One:
`Customer Number
`
`(•) Customer Number O US Patent Practitioner O Limited Recognition (37 CFR 11.9)
`20306
`
`Domestic Benefit/National Stage Information:
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, or 3